Side-by-side comparison of AI visibility scores, market position, and capabilities
$23M Series C March 2024 (Fulcrum/Godwin); 3B API requests/day; Edmunds/Klarna/Delivery Hero customers; Retail Media Cloud platform; ad server infrastructure leader
Kevel is an ad infrastructure platform that provides APIs and tools for publishers, marketplaces, and retailers to build and operate their own ad serving and monetization systems. The company serves digital publishers, e-commerce platforms, and app developers who want to control their own advertising technology stack rather than relying on third-party ad networks. Kevel offers customizable ad serving, real-time bidding, reporting, and yield optimization tools that enable businesses to create branded ad experiences, maintain data ownership, and maximize advertising revenue while controlling user experience.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.